Next DestiniesNext Destinies🃏All Zebstrika cards
Ask about Zebstrika
Zebstrika #48 Pokémon card from Next Destinies

Zebstrika 48/99

Next Destinies

Find this card on eBay

Affiliate link · we may earn commission

Zebstrika #48 from Next Destinies currently trades at $0.74 raw, with PSA 10 copies reaching $38.68 — a 52.3x grade premium.
Current Prices (USD)
Ungraded
$0.74
PSA 7
$13.76
PSA 8
$13.76
PSA 9
$13.76
PSA 10
$38.68
ACE 10
BGS 10 Black
$250.00
CGC 10 Pristine
$41.00
Compare on eBay

Affiliate link · we may earn commission

Quick price facts

Zebstrika 48/99 from Next Destinies has a current raw market value of $0.74.

Current raw value
$0.74
PSA 9 value
$13.76
PSA 10 value
$38.68
PSA 10 premium vs raw
52.3× raw
View all cards from Next Destinies
Collector Intel
52.3x
Raw → PSA 10
High-risk grade
18.6x
Raw → PSA 9
Grade multiplier

Calculated from price history, PSA population data, and market trends. Not financial advice.

Grading Calculator

Based on PSA Standard tier (~$25 USD). Assumes a perfect PSA 10 result — actual outcome depends on card condition.

⚠️ High-variance grade. PSA 10 is 52x the raw price. The expected value accounts for the realistic probability.
$1
Buy Raw
~$25
Grading Fee
PSA Standard
$39
PSA 10 Value
+$13
Best Case (PSA 10)
if you pull a 10
Grade Multiples vs Raw
PSA 9$1418.6x raw
PSA 10$3952.3x raw

Frequently asked questions

How much is Zebstrika #48 from Next Destinies worth?+
Zebstrika #48 from Next Destinies is currently worth Raw: $0.74, PSA 9: $13.76, PSA 10: $38.68 based on recent sold listings. Prices update daily from real eBay sales.
Is Zebstrika #48 worth grading?+
The PSA 10 price of $38.68 is 52.3× the raw price of $0.74. After a ~$25 grading fee, a PSA 10 result would net approximately $37.94 — assuming the card grades a 10.
Where do PokePrices Zebstrika #48 prices come from?+
Prices are tracked nightly from real sold listings on PriceCharting (raw, PSA 9 and PSA 10). PSA population data is sourced from PSA's public reports. We do not use asking prices — only confirmed sales.